全部资讯｜CELL INTELLIGENCE

Current and Emerging Targeted Therapy in Advanced Gastroesophageal Adenocarcinoma.

PubMed 2026/09/08 发表Pharmaceuticals (Basel)Q1 · IF 5.7（JCR 2025）

背景/目的：晚期胃食管腺癌（GEA）预后不良，尽管采用标准化疗，中位总生存期仍为13-20个月。

Antibody-Mediated Therapy in Gastric Cancer: Past, Present, and Future.

PubMed 2025/12/15 发表Curr Issues Mol BiolQ2 · IF 4.1（JCR 2025）

Therapeutic advances in the targeting of ROR1 in hematological cancers.

PubMed 2024/11/17 发表Cell Death DiscovQ1 · IF 10.4（JCR 2025）

全部资讯 3